---
title: "Covista | 8-K: FY2026 Q3 Revenue: USD 487.03 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285656797.md"
datetime: "2026-05-08T03:14:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285656797.md)
  - [en](https://longbridge.com/en/news/285656797.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285656797.md)
generator: "portal-rs"
---

# Covista | 8-K: FY2026 Q3 Revenue: USD 487.03 M

Revenue: As of FY2026 Q3, the actual value is USD 487.03 M.

EPS: As of FY2026 Q3, the actual value is USD 1.2.

EBIT: As of FY2026 Q3, the actual value is USD 104.97 M.

#### Overall Performance

Covista Inc. reported a total student enrollment of 100,585, marking a 6.8% year-over-year (YoY) increase and achieving its 11th consecutive quarter of growth. Revenue for the quarter reached $487.0 million, up 4.5% YoY, or 8.4% YoY when adjusted for a one-week academic shift at Walden University. GAAP net income was $41.6 million, compared to $60.8 million in the prior year. Adjusted EBITDA was $127.9 million, a slight increase from $127.8 million in the prior year, with an adjusted EBITDA margin of 26.3% compared to 27.4% previously. Operating income stood at $91.3 million, up from $90.5 million, while adjusted operating income was $102.2 million, down from $105.4 million YoY. Total operating cost and expense for the three months ended March 31, 2026, was $395,688 thousand, up from $375,546 thousand in the prior year. For the nine months ended March 31, 2026, total operating cost and expense was $1,164,770 thousand, compared to $1,066,567 thousand in the prior year.

#### Capital Allocation

Covista Inc. repurchased $66 million of shares during the third quarter. The company refinanced its outstanding debt, consolidating it into a $510 million Term Loan B with an extended maturity to 2033. Net leverage as of March 31, 2026, was reported at 0.7x.

#### Cash Flow (Nine Months Ended March 31, 2026)

Net cash provided by operating activities was $346,459 thousand, increasing from $278,207 thousand in the prior year. Net cash provided by operating activities-continuing operations was $346,414 thousand, up from $273,813 thousand. Free cash flow for the trailing twelve months ended March 31, 2026, was $336,463 thousand. Capital expenditures for the nine months ended March 31, 2026, were $50,882 thousand, compared to $31,337 thousand in the prior year.

#### Segment Performance (Three Months Ended March 31, 2026 vs 2025)

##### Chamberlain

-   **Revenue:** $197.0 million, up 2.3% from $192.6 million.
-   **Operating Income:** $47.7 million, up 0.4% from $47.5 million.
-   **Adjusted Operating Income:** $47.9 million, up 0.8% from $47.5 million.
-   **Adjusted EBITDA:** $58.5 million, up 2.9% from $56.8 million.
-   **Total Students:** 40,767, up 0.5% from 40,564, driven by growth in pre-licensure nursing.

##### Walden

-   **Revenue:** $186.6 million, up 4.6% from $178.4 million.
-   **Operating Income:** $39.5 million, down -12.5% from $45.2 million.
-   **Adjusted Operating Income:** $42.4 million, down -11.7% from $48.0 million.
-   **Adjusted EBITDA:** $49.7 million, down -7.9% from $54.0 million.
-   **Total Students:** 54,474, up 12.3% from 48,526, driven by growth in healthcare and non-healthcare programs.

##### Medical and Veterinary

-   **Revenue:** $103.5 million, up 8.9% from $95.0 million.
-   **Operating Income:** $21.1 million, up 18.7% from $17.8 million.
-   **Adjusted Operating Income:** $21.5 million, up 20.0% from $17.9 million.
-   **Adjusted EBITDA:** $27.5 million, up 20.1% from $22.9 million.
-   **Total Students:** 5,344, up 4.1% from 5,133, driven by growth in both medical and veterinary.

#### Fiscal Year 2026 Outlook

Covista Inc. raised its fiscal year 2026 revenue guidance to a range of $1,930 million to $1,945 million, representing approximately 8% to 9% growth YoY, an increase from the previous range of $1,900 million to $1,940 million. The company also increased its adjusted earnings per share guidance to $7.95 to $8.15, indicating approximately 19% to 22% growth YoY, compared to the prior range of $7.80 to $8.00.

### Related Stocks

- [CVSA.US](https://longbridge.com/en/quote/CVSA.US.md)

## Related News & Research

- [Jefferies Sticks to Its Buy Rating for Covista (CVSA)](https://longbridge.com/en/news/296118987.md)
- [Covista Q4 revenue beats analyst estimates on record enrollment levels](https://longbridge.com/en/news/295140652.md)
- [Tribe Property Technologies Inc. reports Q2 results](https://longbridge.com/en/news/296953133.md)
- [JOYY beats top-line and bottom-line estimates; gives FY 2026 outlook](https://longbridge.com/en/news/296985959.md)
- [LSL Pharma Group Inc. reports Q2 results](https://longbridge.com/en/news/296953883.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**